Table 2.
Odds of Using Contraceptive Method Categories Compared With No Method, Pregnancy Risks Assessment Monitoring System Respondents in 20 Jurisdictions,* 2018
| Variable | Contraceptive Method (Ref: None) | Adjusted‡ Odds Ratio Estimates (95% Confidence Interval) |
|---|---|---|
|
| ||
| Insurance† (ref: private) | ||
| Public | Permanent | 1.07 (0.87–1.31) |
| LARC | 0.91 (0.76–1.09) | |
| SARC | 0.91 (0.77–1.07) | |
| Less effective | 0.67 (0.56–0.79) | |
| No insurance | Permanent | 0.72 (0.53–0.98) |
| LARC | 0.67 (0.51–0.89) | |
| SARC | 0.61 (0.47–0.81) | |
| Less effective | 0.93 (0.72–1.21) | |
| Geographic setting (ref: urban) | ||
| Rural | Permanent | 2.15 (1.67–2.77) |
| LARC | 1.31 (1.04–1.65) | |
| SARC | 1.42 (1.15–1.76) | |
| Less effective | 1.38 (1.11–1.72) | |
Abbreviations: LARC, long-acting reversible contraception, including intrauterine devices and contraceptive implants; SARC, short-acting reversible contraception, including contraceptive pills, patches, rings, and injections.
Jurisdictions included were Alaska, Colorado, Connecticut, Delaware, Illinois, Louisiana, Massachusetts, Maine, Michigan, Missouri, New Jersey, New Mexico, Pennsylvania, Utah, Virginia, Washington, Wisconsin, West Virginia, Wyoming, and New York City.
Insurance coverage at the time the respondent completed the Pregnancy Risks Assessment Monitoring System survey.
Adjusted model includes insurance type, geographic setting, maternal age, race/ethnicity, and parity.